Integrating Biomarker Insights to Guide Dose Selection & Monitor Therapeutic Response in Immuno-Oncology
Time: 11:30 am
day: Conference Day 1
Details:
- How iitune-1 trial utilizes comprehensive biomarker analysis to guide dose selection
- How plasma biomarkers, RNA seq analysis contribute to evaluating innate and adaptive immune responses
- Retrospective analysis into how ctDNA changes correlate with clinical outcomes, to provide insights in its value in monitoring therapeutic efficacy
Immuno-Oncology
